Leonard Valentino: Why Hemophilic Arthropathy Is More Than an Inflammatory Joint Disease
Leonard Valentino, President of WFH USA, shared a post on LinkedIn about a recent article he authored, published in Journal of Thrombosis and Haemostasis, adding:
“I’m excited to share my latest commentary in the Journal of Thrombosis and Haemostasis (JTH): ‘Hemophilic Arthropathy: When Shared Inflammatory Pathways Do Not Imply Shared Pathogenesis.’
For years, we’ve recognized that hemophilic arthropathy shares many inflammatory features with rheumatoid arthritis and osteoarthritis.
Similar cytokines, signaling pathways, synovial inflammation, and tissue remodeling can make these diseases appear biologically connected.
Yet an important question remains: do shared pathways necessarily mean shared mechanisms of disease?
In this commentary, I discuss emerging research suggesting that the answer may be no.
While inflammatory mediators may overlap across joint diseases, hemophilic arthropathy is fundamentally initiated by bleeding into the joint and the unique biological consequences of blood and iron exposure.
These distinct triggers may drive disease progression in ways that cannot be fully understood through comparisons with other arthritides alone.
As we pursue novel therapies to preserve joint health in people with hemophilia, understanding the difference between shared inflammatory signatures and true disease-driving mechanisms is critical.
The most effective treatments will likely come from targeting the pathways that are uniquely relevant to blood-induced joint disease.
I’m grateful to colleagues and investigators whose work continues to deepen our understanding of hemophilic arthropathy and challenge long-held assumptions about its pathogenesis.”
Title: Hemophilic arthropathy: when shared inflammatory pathways do not imply shared pathogenesis
Author: Leonard A. Valentino’

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C